Current Affairs - Science - Discussion

Uganda, in collaboration with the World Health Organization (WHO) and global partners, has initiated the first-ever clinical trial for a vaccine targeting the Sudan species of the Ebola virus. The trial was launched just four days after the outbreak was confirmed on January 30, marking an unprecedented speed for a randomized vaccine trial in an emergency setting. Led by Makerere University and the Uganda Virus Research Institute (UVRI), the trial follows a ring vaccination strategy and is supported by organizations like CEPI, Canada’s IDRC, and Africa CDC. If successful, this vaccine could play a crucial role in future outbreak control.